Related Experiment Video
Updated: Apr 4, 2026

Assessing Activity-based Anorexia in Mice
Published on: May 14, 2018
Liver dysfunction in patients with severe anorexia nervosa.
Elissa Rosen1,2,3, Allison L Sabel4,5, John T Brinton1,2,3
1Department of Medicine, University of Colorado, School of Medicine, Aurora, Colorado.
Liver dysfunction, indicated by elevated liver enzymes, is common in severe anorexia nervosa (AN). These enzyme levels normalized by discharge and were linked to lower BMI and hypoglycemia risk.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Background:
- Liver dysfunction evaluation in severe anorexia nervosa (AN) is often based on limited case series.
- This study investigates liver dysfunction in a large cohort of adults hospitalized for AN medical stabilization.
Purpose of the Study:
- To assess the incidence and characteristics of liver dysfunction in severe AN patients.
- To determine clinical outcomes associated with liver enzyme elevation during hospitalization.
Main Methods:
- Retrospective evaluation of electronic medical records for 181 adult AN patients.
- Quantified incidence of elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT).
- Compared clinical covariates based on liver enzyme elevation severity.
Main Results:
- Mildly elevated AST/ALT in 27.6%, severely elevated in 35.4% of patients.
- Severely elevated enzymes correlated with lower BMI, lower % ideal body weight, and lower prealbumin.
- Patients with severe enzyme elevation had higher rates of hypoglycemia, hypophosphatemia, and longer hospital stays.
Conclusions:
- Elevated liver enzymes are prevalent in severe AN.
- Liver enzymes normalized by hospital discharge.
- Severe enzyme elevation is associated with lower BMI and increased risk of hypoglycemia.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Bulimia Nervosa
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

